abstract |
The present invention relates to crystalline 4-amino-5-fluoro-3- [5- (4-methylpiperazin-1-yl) -1H-benzimidazol-2-yl] quinolin-2 (1H) -one lactic acid salt Forms or polymorphs, and methods for their preparation, pharmaceutical compositions comprising them, and methods of treatment using the same. |